Evidence map›Paper›PMID 32878619›Full record

SynthesisBMC medicine2020

COVID-19 length of hospital stay: a systematic review and data synthesis.

Eleanor M Rees, Emily S Nightingale, Yalda Jafari, Naomi R Waterlow, Samuel Clifford, Carl A B Pearson, Cmmid Working Group, Thibaut Jombart, Simon R Procter, Gwenan M Knight

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in BMC medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05957588 (Non-ventilated Prone Positioning in the COVID-19 Population), which is not on this map. Cited by 322 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
322citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05957588 nacompletednot on this mapstarted 2021, after this paper: background citation

Non-ventilated Prone Positioning in the COVID-19 Population

TypeinterventionalSponsorBaylor St. Luke's Medical CenterRan2021 to 2022Enrolled216ConditionsCOVID-19, Proning, Oxygenation, Length of StayArmsProning group, Control group
3 · Its place in the literature

Who cites it

322 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. COVID-19 in patients with Down syndrome: A systematic review.Immunity, inflammation and disease · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Influence of COVID-19 on Clinical Outcomes ofAntibiotics (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

262 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eleanor M ReesDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK. eleanor.rees1@lshtm.ac.uk.ORCID 0000-0002-4993-2795
Emily S NightingaleDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Yalda JafariDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Naomi R WaterlowDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Samuel CliffordDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Carl A B PearsonDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Cmmid Working GroupDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Thibaut JombartDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Simon R ProcterDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Gwenan M KnightDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

Funding

Medical Research Council MR/P014658/1Medical Research Council MR/S003975/1Wellcome Trust
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has placed an unprecedented strain on health systems, with rapidly increasing demand for healthcare in hospitals and intensive care units (ICUs) worldwide. As the pandemic escalates, determining the resulting needs for healthcare resources (beds, staff, equipment) has become a key priority for many countries. Projecting future demand requires estimates of how long patients with COVID-19 need different levels of hospital care.

methodsWe performed a systematic review of early evidence on length of stay (LoS) of patients with COVID-19 in hospital and in ICU. We subsequently developed a method to generate LoS distributions which combines summary statistics reported in multiple studies, accounting for differences in sample sizes. Applying this approach, we provide distributions for total hospital and ICU LoS from studies in China and elsewhere, for use by the community.

resultsWe identified 52 studies, the majority from China (46/52). Median hospital LoS ranged from 4 to 53 days within China, and 4 to 21 days outside of China, across 45 studies. ICU LoS was reported by eight studies-four each within and outside China-with median values ranging from 6 to 12 and 4 to 19 days, respectively. Our summary distributions have a median hospital LoS of 14 (IQR 10-19) days for China, compared with 5 (IQR 3-9) days outside of China. For ICU, the summary distributions are more similar (median (IQR) of 8 (5-13) days for China and 7 (4-11) days outside of China). There was a visible difference by discharge status, with patients who were discharged alive having longer LoS than those who died during their admission, but no trend associated with study date.

conclusionPatients with COVID-19 in China appeared to remain in hospital for longer than elsewhere. This may be explained by differences in criteria for admission and discharge between countries, and different timing within the pandemic. In the absence of local data, the combined summary LoS distributions provided here can be used to model bed demands for contingency planning and then updated, with the novel method presented here, as more studies with aggregated statistics emerge outside China.

Indexed as

Coronavirus InfectionsHealth Care RationingLength of StayPneumonia, ViralBetacoronavirusCOVID-19Hospital Bed CapacityHospitalizationHumansIntensive Care UnitsPandemicsSARS-CoV-2Bed demandCOVID-19HospitalisationICU capacityLength of staySARS-CoV-2

Identifiers

PMID32878619
PMCPMC7467845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.